FormFactor stock hits all-time high at 136.0 USD

FormFactor reported Q4 2025 EPS of $0.46 versus $0.35 expected and revenue of $215.2 million versus $210.25 million expected, a 31.43% EPS surprise. Cantor Fitzgerald raised its price target to $125 from $100 and kept an Overweight rating, although the stock traded lower during regular hours despite the beat. The shares have also surged 407% over the past year to an all-time high of $136, leaving the stock at 196.52x P/E and flagged as overvalued/overbought.

Analysis

FORM’s setup looks more like a positioning/expectations problem than a clean fundamentals story. A stock up this far this fast with an elevated multiple is vulnerable to any indication that revenue beats are being absorbed by capacity bottlenecks rather than translating into durable margin expansion; that usually caps the next leg of upside even when orders stay healthy. The key second-order effect is that the market may be front-running a multi-quarter cycle inflection, so any guide that is merely good—not exceptional—can trigger de-rating before the underlying semiconductor equipment demand actually rolls over.

The more interesting read-through is on the broader test and metrology chain: if FORM is capacity-constrained, that can signal stronger near-term demand at the high end of advanced packaging/leading-edge inspection, which should be supportive for peers with similar customer exposure but less stretched valuation. However, if the demand is concentrated in a narrow set of customers, the upside becomes fragile and increasingly dependent on a small number of capex programs; that raises tail risk if AI-related spending pauses or gets rephased for even one quarter.

From a timing perspective, the next 2-6 weeks matter more than the next 12 months. The stock’s technical stretch suggests the risk/reward is skewed toward mean reversion unless the next catalyst includes a materially higher guide or evidence that supply constraints are being relieved without diluting margins. The contrarian view is that investors are treating FORM like a cyclical growth compounder when it may actually be a peak-earnings multiple story until capacity expands.

Key Decisions for Investors

• Take profits or trim longs in FORM into strength; reward/risk is poor after a large multi-quarter rerating unless the next print proves margin leverage, not just top-line beat.
• If maintaining exposure, use a collar or put spread over the next 4-8 weeks to protect against an overbought reset; downside can compress quickly if guidance is only in line.
• Relative-value trade: long a lower-multiple metrology/inspection peer basket vs short FORM, looking for valuation normalization if FORM's capacity constraints keep capping upside.
• Watch for a post-earnings pullback toward prior breakout levels before re-entering; if the stock retraces 10-15% without a change in fundamentals, that is a better entry than chasing momentum.
• For bullish expression, prefer call spreads rather than outright equity: limited premium outlay captures upside if the next guide is a true raise, while defining risk if the market decides the growth is already priced.